[Clinical use of synthetic thyroliberin (thyrotropin-releasing factor)].
D001702:Biopharmaceutics; D001927:Brain Diseases / Q000188:drug therapy; D004392:Dwarfism / Q000188:drug therapy; D005094:Exophthalmos / Q000188:drug therapy; D005260:Female; D006042:Goiter / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007031:Hypothalamus / Q000187:drug effects; D007037:Hypothyroidism / Q000188:drug therapy; D008297:Male; D011388:Prolactin / Q000378:metabolism; D013961:Thyroid Gland / Q000187:drug effects; D013972:Thyrotropin / Q000037:antagonists & inhibitors; D013973:Thyrotropin-Releasing Hormone / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D013974:Thyroxine / Q000502:physiology; D013997:Time Factors; D014284:Triiodothyronine / Q000502:physiology
D014284:Triiodothyronine; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D013972:Thyrotropin; D013974:Thyroxine
Klinicheskoe primenenie sinteticheskogo tiroliberina (tireotropin-rilizing-faktora).